Clinical Trials Directory

Trials / Conditions / Refractory Thyroid Gland Carcinoma

Refractory Thyroid Gland Carcinoma

6 registered clinical trials studyying Refractory Thyroid Gland Carcinoma.

StatusTrialSponsorPhase
CompletedEvaluation of 177Lu-DOTA-EB-FAPI in Patients With Metastatic Radioactive Iodine Refractory Thyroid Cancer
NCT05410821
The First Affiliated Hospital of Xiamen UniversityPhase 1
Active Not RecruitingEncorafenib and Binimetinib With or Without Nivolumab in Treating Patients With Metastatic Radioiodine Refract
NCT04061980
Providence Health & ServicesPhase 2
Active Not RecruitingTipifarnib for the Treatment of Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With HRAS Gene Alter
NCT04284774
National Cancer Institute (NCI)Phase 2
Active Not RecruitingTesting the Combination of Cabozantinib, Nivolumab, and Ipilimumab (CaboNivoIpi) for Advanced Differentiated T
NCT03914300
National Cancer Institute (NCI)Phase 2
Active Not RecruitingTrametinib in Increasing Tumoral Iodine Incorporation in Patients With Recurrent or Metastatic Thyroid Cancer
NCT02152995
National Cancer Institute (NCI)Phase 2
CompletedSunitinib Malate in Treating Patients With Thyroid Cancer That Did Not Respond to Iodine I 131 and Cannot Be R
NCT00381641
National Cancer Institute (NCI)Phase 2